The insulin‐like growth factor I generation test in the investigation of short stature
Authors:
- 1 April 1994
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 83 (s399) , 128-130
Abstract
Genotypic and phenotypic heterogeneity in patients with growth hormone (GH) insensitivity syndrome suggests that partial defects exist in the GH receptor. The insulin-like growth factor I (IGF-I) generation test was assessed as a means of identifying partial GH receptor defects in a heterogeneous group of 22 prepubertal children with short stature. In a subgroup of nine patients with peak GH levels of 63.7 +/- 3.7 mU/l during a glucagon tolerance test, the response to the IGF-I generation test was no different from that for the group as a whole (peak GH, 43.3 +/- 4.5 mU/l), despite the fact that this subgroup exhibited a negative relationship between height SDS and peak GH and a positive relationship between height SDS and IGF binding protein-3. This preliminary study therefore suggests that the IGF-I generation test in its present form will not be useful as a primary screening test for partial GH insensitivity. Despite this, the IGF-I generation test has been extremely useful in the confirmation of the diagnosis of GHIS and may therefore also prove useful in the confirmation of partial defects in the GH receptor. A subgroup of short children with peak GH levels above 40 mU/l had some characteristics of partial GH receptor deficiency. These children, to whom GH therapy would not normally be given, may respond better to recombinant human IGF-I.Keywords
This publication has 10 references indexed in Scilit:
- Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfallsActa Paediatrica, 1994
- Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorean E180splice mutation in an oriental Jewish patientActa Paediatrica, 1994
- Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)The Journal of Clinical Endocrinology & Metabolism, 1993
- The effect of recombinant human insulin‐like growth factor‐I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)Clinical Endocrinology, 1993
- Laron Dwarfism and Mutations of the Growth Hormone–Receptor GeneNew England Journal of Medicine, 1989
- Prospective clinical trial of human growth hormone in short children without growth hormone deficiencyThe Journal of Pediatrics, 1984
- Growth Hormone Treatment for Short StatureNew England Journal of Medicine, 1983
- Human Growth Hormone Treatment of Children with Growth Failure and Normal Growth Hormone Levels by Immunoassay: Lack of Correlation with Somatomedin GenerationPediatrics, 1983
- Effects of Prolonged Dopamine Infusion on Anterior Pituitary Function in Normal Males*The Journal of Clinical Endocrinology & Metabolism, 1981
- Children with Normal-Variant Short Stature: Treatment with Human Growth Hormone for Six MonthsNew England Journal of Medicine, 1981